Hamilton Thorne Ltd.
HTL
Peringkat dalam Saham
#16953
Hamilton Thorne Ltd. is a leading enterprise focused on the development,... Hamilton Thorne Ltd. is a leading enterprise focused on the development, manufacturing, and global distribution of specialized instrumentation, laboratory equipment, consumables, software, and a range of services. The company's offerings are primarily directed towards the fields of assisted reproductive technologies (ART), scientific research, and cell biology. Their product line includes sophisticated laser and imaging systems designed for biological studies, custom-built workstations, incubators, and essential equipment for IVF laboratories. They also produce critical medical devices for reproductive medicine, such as ovum pickup needles and catheters, and provide comprehensive in-vitro diagnostic (IVD) systems, from initial research and design to sales, installation, and ongoing servicing. Environmental control solutions like the Cell-Tek Microscope Chamber, which meticulously manages temperature, airflow, and humidity, are also part of their extensive catalog, alongside laminar flow workstations. Furthermore, Hamilton Thorne pioneers software innovations, including AI-powered CASA (Computer-Assisted Sperm Analysis) for image analysis. The company's service array covers thorough laboratory testing, notably endotoxin analysis and specialized sperm assays (like the Sperm Motility Index and Sperm Penetration), as well as the provision of fresh and cryopreserved mouse embryos, coupled with technician training and proficiency testing programs. Marketed under respected brand names such as Hamilton Thorne, Gynemed, Planer, Tek-Event, IVFtech, MICROPTIC, Gynétics, and Embryotech, their products and services reach a diverse global customer base—including fertility clinics, hospitals, pharmaceutical and biotechnology companies, academic institutions, and various commercial research entities—via a direct sales presence in countries like the United States, Germany, France, Australia, Denmark, Belgium, Spain, and the United Kingdom, complemented by an extensive distributor network covering around 100 nations. Hamilton Thorne Ltd. maintains its headquarters in Beverly, Massachusetts.
Harga Saham
$1.64
Terakhir disinkronkan: 2024-12-02
Kapitalisasi Pasar
$253.46M
Perubahan (1 hari)
2.87%
Perubahan (1 tahun)
3.40%
Negara
US
Perdagangan Hamilton Thorne Ltd. (HTL)
Kategori
Healthcare
Rasio P/E untuk Hamilton Thorne Ltd. (HTL)
Rasio P/E per October 2026 TTM: -387.83
Menurut laporan keuangan dan harga saham terbaru dari Hamilton Thorne Ltd., rasio P/E saat ini (TTM) adalah -387.83. Pada akhir 2022, perusahaan memiliki rasio P/E sebesar 91.33.
Riwayat rasio P/E untuk Hamilton Thorne Ltd. dari 2008 hingga 2026
Rasio P/E di akhir setiap tahun
| Tahun | Rasio P/E | Mengubah |
|---|---|---|
| 2026 (TTM) | -387.83 | 59.24% |
| 2023 | -243.55 | -366.69% |
| 2022 | 91.33 | -4.30% |
| 2021 | 95.43 | -39.39% |
| 2020 | 157.45 | 26.56% |
| 2019 | 124.41 | 371.95% |
| 2018 | 26.36 | 161.23% |
| 2017 | 10.09 | -72.34% |
| 2016 | 36.48 | 279.55% |
| 2015 | 9.61 | -56.10% |
| 2014 | 21.90 | 14.40% |
| 2013 | 19.14 | -996.31% |
| 2012 | -2.14 | 72.31% |
| 2011 | -1.24 | 28.28% |
| 2010 | -0.97 | 40.85% |
| 2009 | -0.69 | 565.28% |
| 2008 | -0.10 | 0.00% |
Rasio P/E untuk perusahaan serupa atau pesaing
| Perusahaan | Rasio P/E | Perbedaan Rasio P/E | Negara |
|---|---|---|---|
| 47.48 | -112.24% |
US
|
|
| 27.43 | -107.07% |
FR
|
|
| - | - |
JP
|
|
| 56.89 | -114.67% |
US
|
|
| - | - |
CH
|
Bagaimana cara membaca P/E ratio?
Rasio Harga/Laba (P/E) mengukur hubungan antara harga saham perusahaan dan laba per sahamnya.
P/E yang rendah namun positif menunjukkan perusahaan dengan laba tinggi dibandingkan valuasinya saat ini dan mungkin dianggap undervalued. P/E negatif tinggi (mendekati 0) menunjukkan perusahaan yang mengalami kerugian besar.
Perusahaan dengan P/E di atas 30 atau negatif umumnya dianggap sebagai "saham pertumbuhan", artinya investor mengharapkan pertumbuhan atau keuntungan di masa depan.
Perusahaan dengan P/E positif di bawah 10 dianggap sebagai "saham bernilai", artinya perusahaan sudah sangat menguntungkan dan pertumbuhannya kemungkinan tidak besar.